Celera Acquired By Quest Diagnostics For $327M
Alameda-based Celera, which develops genetic diagnostics technology, has been acquired by Quest Diagnostics, the firms said this morning. According to the two, Quest Diagnostics will pay $8 per share, or approximately $344M, for Celera, for a net transacation value of $327M including cash and short term investments acquired. the companies said Celera had revenues of $128M in 2010.
posted on Friday, March 18, 2011
Related companies:
Celera
Related stories:
> Celera Buys Berkeley HeartLab For $195M
> Celera Splits From Applera
> MonoSphere Acquired By Quest Software
> SanDisk Buys Pliant For $327M
> Ascend Clinical Buys PathCentral's Diagnostics Lab Unit
silicontap.com Home